Vaccination Status and Outcomes in Critical COVID-19 Patients

Overview

Journal J Bras Pneumol

Specialty Pulmonary Medicine

Date 2024 Feb 29

PMID 38422336

Authors

Pedro Nogueira Costa

Joao Oliveira Pereira

Aurea Higon Canigral

Elena Martinez Quintana

Juan Miguel Sanchez-Nieto

Pablo Bayoumy Delis

Ana Renedo Villarroya

Laura Lopez Gomez

Nuria Alonso Fernandez

Andres Carrillo Alcaraz

Affiliations

Soon will be listed here.

Abstract

Objective: To analyze the clinical characteristics and outcomes of patients with COVID-19-related acute respiratory failure on the basis of their vaccination status at the time of ICU admission.

Methods: We conducted a retrospective observational study using a prospective database of patients admitted to the ICU of a university hospital in the city of Murcia, in Spain, between January 1, 2021 and September 1, 2022. Clinical, analytical, and sociodemographic data were collected and analyzed on the basis of patient vaccination status. We adjusted for confounding variables using propensity score matching and calculated adjusted ORs and 95% CIs.

Results: A total of 276 patients were included in the study. Of those, 8.3% were fully vaccinated, 12% were partially vaccinated, and 79.7% were unvaccinated. Although fully vaccinated patients had more comorbidities, partially vaccinated patients had higher disease severity. The proportion of patients with severe acute respiratory failure was higher in the unvaccinated group, followed by the partially vaccinated group. No significant differences were found among the different groups regarding complications, duration of ventilatory support, or length of ICU/hospital stay. In the sample selected by propensity score matching, the number of patients with severe complications and the in-hospital mortality rate were higher in unvaccinated patients, but the differences were not significant.

Conclusions: This study failed to show a significant improvement in outcomes in critically ill COVID-19 patients vaccinated against SARS-CoV-2. However, the CIs were wide and the mortality point estimates favored patients who received at least one dose of COVID-19 vaccine.

References

Grana C, Ghosn L, Evrenoglou T, Jarde A, Minozzi S, Bergman H . Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022; 12:CD015477. PMC: 9726273. DOI: 10.1002/14651858.CD015477. View

Rzymski P, Kasianchuk N, Sikora D, Poniedzialek B . COVID-19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS-CoV-2 Omicron wave in the first quarter of 2022. J Med Virol. 2022; 95(1):e28131. PMC: 9537885. DOI: 10.1002/jmv.28131. View

Semenzato L, Botton J, Baricault B, Deloumeaux J, Joachim C, Sylvestre E . Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System. PLoS One. 2022; 17(9):e0274309. PMC: 9462750. DOI: 10.1371/journal.pone.0274309. View

Hodgson S, Mansatta K, Mallett G, Harris V, Emary K, Pollard A . What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2020; 21(2):e26-e35. PMC: 7837315. DOI: 10.1016/S1473-3099(20)30773-8. View

Federico M . How Do Anti-SARS-CoV-2 mRNA Vaccines Protect from Severe Disease?. Int J Mol Sci. 2022; 23(18). PMC: 9499329. DOI: 10.3390/ijms231810374. View

Abu-Raddad L, Chemaitelly H, Ayoub H, Almukdad S, Yassine H, Al-Khatib H . Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar. N Engl J Med. 2022; 386(19):1804-1816. PMC: 8929389. DOI: 10.1056/NEJMoa2200797. View

Baum U, Poukka E, Leino T, Kilpi T, Nohynek H, Palmu A . High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron. BMC Infect Dis. 2022; 22(1):816. PMC: 9636823. DOI: 10.1186/s12879-022-07814-4. View

Wada N, Li Y, Hino T, Gagne S, Valtchinov V, Gay E . COVID-19 Vaccination reduced pneumonia severity. Eur J Radiol Open. 2022; 9:100456. PMC: 9650570. DOI: 10.1016/j.ejro.2022.100456. View

Vincent J, Moreno R, Takala J, Willatts S, de Mendonca A, Bruining H . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22(7):707-10. DOI: 10.1007/BF01709751. View

10.

Le Gall J, Lemeshow S, Saulnier F . A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993; 270(24):2957-63. DOI: 10.1001/jama.270.24.2957. View

11.

Morales Varas G, Sanchez Casado M, Padilla Peinado R, Moran Gallego F, Buj Vicente M, Rodriguez Villamizar A . Effects of vaccination against COVID-19 on the evolution of critically ill patients. Med Intensiva (Engl Ed). 2022; 46(10):588-590. PMC: 9250934. DOI: 10.1016/j.medine.2022.06.017. View

12.

Gram M, Emborg H, Schelde A, Friis N, Nielsen K, Moustsen-Helms I . Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study. PLoS Med. 2022; 19(9):e1003992. PMC: 9436060. DOI: 10.1371/journal.pmed.1003992. View

13.

Rotshild V, Hirsh-Raccah B, Miskin I, Muszkat M, Matok I . Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Sci Rep. 2021; 11(1):22777. PMC: 8611039. DOI: 10.1038/s41598-021-02321-z. View

14.

Tartof S, Slezak J, Fischer H, Hong V, Ackerson B, Ranasinghe O . Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021; 398(10309):1407-1416. PMC: 8489881. DOI: 10.1016/S0140-6736(21)02183-8. View

15.

Singhal J, Goel C, Gupta V, Sachdeva M, Sanjappa S, Koushal V . Comparison of Imaging Severity Between Vaccinated and Unvaccinated COVID-19 Patients: Perspective of an Indian District. Cureus. 2022; 14(10):e30724. PMC: 9671272. DOI: 10.7759/cureus.30724. View

16.

Johnson S, Mielke N, Mathew T, Maine G, Chen N, Bahl A . Predictors of hospitalization and severe disease due to breakthrough SARS-CoV-2 infection in fully vaccinated individuals. J Am Coll Emerg Physicians Open. 2022; 3(4):e12793. PMC: 9337843. DOI: 10.1002/emp2.12793. View

17.

Tenforde M, Self W, Adams K, Gaglani M, Ginde A, McNeal T . Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity. JAMA. 2021; 326(20):2043-2054. PMC: 8569602. DOI: 10.1001/jama.2021.19499. View

18.

Grapsa E, Adamos G, Andrianopoulos I, Tsolaki V, Giannakoulis V, Karavidas N . Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19-Related Acute Respiratory Distress Syndrome. JAMA Netw Open. 2022; 5(10):e2235219. PMC: 9547321. DOI: 10.1001/jamanetworkopen.2022.35219. View

19.

Korang S, von Rohden E, Veroniki A, Ong G, Ngalamika O, Siddiqui F . Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials. PLoS One. 2022; 17(1):e0260733. PMC: 8782520. DOI: 10.1371/journal.pone.0260733. View

20.

Keykavousi K, Nourbakhsh F, Abdollahpour N, Fazeli F, Sedaghat A, Soheili V . A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease. Int J Anal Chem. 2022; 2022:9006487. PMC: 9578918. DOI: 10.1155/2022/9006487. View